Hikma Pharmaceuticals PLC (HKMPF)
24.50
0.00 (0.00%)
USD |
OTCM |
May 24, 16:00
Hikma Pharmaceuticals Total Liabilities (Quarterly): 2.471B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.471B |
| June 30, 2023 | 2.417B |
| June 30, 2023 | 2.417B |
| December 31, 2022 | 2.323B |
| June 30, 2022 | 2.556B |
| June 30, 2022 | 2.556B |
| December 31, 2021 | 1.905B |
| June 30, 2021 | 1.877B |
| June 30, 2021 | 1.877B |
| December 31, 2020 | 1.987B |
| June 30, 2020 | 2.07B |
| June 30, 2020 | 2.07B |
| December 31, 2019 | 1.801B |
| June 30, 2019 | 1.762B |
| June 30, 2019 | 1.762B |
| December 31, 2018 | 1.80B |
| June 30, 2018 | 1.804B |
| June 30, 2018 | 1.804B |
| December 31, 2017 | 1.86B |
| June 30, 2017 | 1.94B |
| June 30, 2017 | 1.94B |
| December 31, 2016 | 1.952B |
| June 30, 2016 | 2.103B |
| June 30, 2016 | 2.103B |
| December 31, 2015 | 1.245B |
| Date | Value |
|---|---|
| June 30, 2015 | 1.233B |
| June 30, 2015 | 1.233B |
| December 31, 2014 | 1.035B |
| June 30, 2014 | 896.00M |
| June 30, 2014 | 896.00M |
| December 31, 2013 | 895.00M |
| June 30, 2013 | 834.91M |
| June 30, 2013 | 834.91M |
| December 31, 2012 | 882.00M |
| June 30, 2012 | 875.83M |
| June 30, 2012 | 875.83M |
| December 31, 2011 | 777.01M |
| June 30, 2011 | 628.57M |
| December 31, 2010 | 349.52M |
| June 30, 2010 | 366.05M |
| December 31, 2009 | 339.47M |
| June 30, 2009 | 358.35M |
| December 31, 2008 | 357.46M |
| June 30, 2008 | 359.50M |
| December 31, 2007 | 469.38M |
| June 30, 2007 | 221.66M |
| December 31, 2006 | 138.55M |
| June 30, 2006 | 104.42M |
| December 31, 2005 | 110.48M |
| June 30, 2005 | 131.71M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.762B
Minimum
Jun 2019
2.556B
Maximum
Jun 2022
2.123B
Average
2.07B
Median
Jun 2020
Total Liabilities (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 233.64M |
| Biodexa Pharmaceuticals Plc | 7.470M |
| Verona Pharma PLC | 64.92M |
| NuCana PLC | 18.52M |
| Autolus Therapeutics PLC | 319.41M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.68B |
| Shareholders Equity (Quarterly) | 2.198B |
| Debt to Equity Ratio | 0.5118 |
| Current Ratio | 1.568 |
| Net Debt Paydown Yield | 2.27% |